Treating urine infections is becoming increasingly challenging due to rising antibiotic resistance. Here's what's driving ...

GennaMD provides bacteria-fighting power in a small capsule, powered by 36 mg of soluble PAC derived only from 100% cranberry ...

Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

Urinary tract infectionss are not an inevitable part of aging. With the right combination of medical treatments and lifestyle ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

Researchers from the University of Liverpool have worked on a UCL-led study that illustrates efforts to reduce child ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

Although the use of colistin is considered to be effective, other antibiotics are often used in combination with colistin. Many studies have shown good outcomes for patients treated with colistin ...

It may be our old friend, the microbe, who mounts a counter-offensive by evolving around our best antibiotics and then pruning our numbers and obliterating our economies back to a pre-industrial ...

His specialty is antibiotic-associated diarrhea. Guenter J Krejs is a Full Professor of Medicine and Chairman of the Department of Internal Medicine and Gastroenterology at Graz University Medical ...

Exposure to antibiotics following FMT may lead to recurrent CDI, suggesting the need for modified strategies to prevent recurrent CDI in some patients.